Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 74

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 74
---
 section titled “The Support Agreements.”

Quorum and Broker Non-Votes

In order to conduct any business at the Special Meeting, a quorum must be present virtually or represented by proxy. Holders of shares
representing at least a majority of the total outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock on the record date entitled to vote at the Special Meeting, represented virtually or by proxy, constitute a quorum.
Enfusion Stockholders choosing to abstain from voting will be treated as present for purposes of determining whether a quorum is present, but will not be counted as votes cast “FOR” any matter.

Banks, brokerage firms and other nominees who hold shares in “street name” for the accounts of their clients may vote such shares
either as directed by their clients or in their own discretion on “routine” matters. When a broker does not receive instructions from a beneficial owner on how to vote shares with respect to a
“non-routine” matter, a broker “non-vote” occurs. Because neither the Merger Agreement Proposal nor the Adjournment Proposal will be considered
“routine,” broker “non-votes” will not be treated as present for purposes of determining whether a quorum is present and will not be counted as votes cast “FOR” any matter. A
broker non-vote, if any, will have the same effect as a vote “AGAINST” the Merger Agreement Proposal and will not have any effect on the Adjournment Proposal (assuming a quorum is present).

Your shares will be counted for purposes of determining if there is a quorum, whether representing votes for, against or abstained, if you
(1) participate in the Special Meeting, or (2) have voted via the Internet, by telephone or by properly submitting a proxy card or voting instruction card by mail.

Required Vote

The votes required for each proposal are as follows:

Proposal 1—The Merger Agreement Proposal. The affirmative vote, virtually or by proxy, of holders of at least a majority of
the outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock

46

entitled to vote on the Merger Agreement Proposal is required to approve the Merger Agreement Proposal. If you are an Enfusion Stockholder on the record date and take any action other than voting (or causing your shares to be voted) “FOR” the Merger Agreement Proposal, it will have the same effect as a vote “AGAINST” the Merger Agreement Proposal